Curidium Discovers Significant Diagnostic Gene Expression Profiles in Blood of Schizophrenia And Bipolar Patients 
Curidium Medica plc, today announced that it has discovered the existence of four unique and statistically significantly different diagnostic gene expression profiles in blood samples from schizophrenia/bipolar disorder patients.